-
-
-
-
-
-
-
FY 2025 Results: Strong Commercial Growth, Focused Pipeline Investment
-
-
-
-
-
-
-
Telix Completes Acquisition of Next-Generation Therapeutic Assets and Innovative Biologics Technology Platform
-
-
-
-
-
-
-
Q1 2024 Revenue and Business Update
-
-
-
-
-
-
-
Mauna Kea Technologies and Telix Pharmaceuticals to Expand Partnership in Uro-oncologic Surgery
-
-
-
-
-
-
-
Telix Reports Q1 2023 Financial Results: Delivers First $100M Revenue Quarter
-
-
-
-
-
-
-
Portland Investment Counsel Inc. Leads Investment in Telix Pharmaceuticals Limited via Private Placement
-
-
-
1,206,810 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


